Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:02 AM
Ignite Modification Date:
2025-12-25 @ 2:02 AM
NCT ID:
NCT00006360
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically proven stage II or III (T1-T2, N0-N1) squamous cell carcinoma of the oropharynx (tonsil, base of tongue, or palate)
* Lymph nodes in both sides of neck at risk of metastatic disease and require radiotherapy
* Patients upstaged by imaging to N2 are eligible
* Measurable or evaluable disease
* Greater than 1 cm in one dimension or with necrotic regions if by CT or MRI scan
* Surgery of the primary tumor or lymph nodes limited to incisional or excisional biopsies
* No distant metastases
PATIENT CHARACTERISTICS:
Age:
* Over 18
Performance status:
* Zubrod 0-1
Life expectancy:
* Not specified
Hematopoietic:
* Not specified
Hepatic:
* Not specified
Renal:
* Not specified
Other:
* No active untreated infection
* No other malignancy within the past 5 years except nonmelanoma skin cancer or a carcinoma not of head or neck origin
* No concurrent major medical or psychiatric illness that would preclude study
PRIOR CONCURRENT THERAPY:
Biologic therapy:
* Not specified
Chemotherapy:
* More than 3 months since prior chemotherapy
* No concurrent chemotherapy
Endocrine therapy:
* Not specified
Radiotherapy:
* No prior head or neck radiotherapy
Surgery:
* See Disease Characteristics
Other:
* No other concurrent treatment for head and neck cancer
* No prophylactic amifostine or pilocarpine
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
120 Years
Study:
NCT00006360
Study Brief:
Protocol Section:
NCT00006360